Acumen Pharmaceuticals, Inc. (ABOS) vs Inogen, Inc. (INGN)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and Inogen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.05HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
INGN
Inogen, Inc.
$5.90HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ABOS vs INGN
growth of $100 · dividends reinvested · last 5yABOS -89.4% (-36.2%/yr)INGN -90.9% (-38.1%/yr)ABOS compounded faster over this window
ABOS INGN
ABOS vs INGN: by the numbers
- •INGN is the larger company ($160M vs $148M market cap).
- •Both run net losses; ABOS's is the smaller (0.00% vs -6.94% net margin).
Metrics side by side
Valuation
| Metric | ABOS | INGN |
|---|---|---|
| P/S ratio | N/A | 0.45 |
| P/B ratio | 2.59 | 0.91 |
Profitability
| Metric | ABOS | INGN |
|---|---|---|
| Gross margin | 0.00% | 48.89% |
| Operating margin | 0.00% | -8.45% |
| Net margin | 0.00% | -6.94% |
| ROE | -183.44% | -14.07% |
| ROIC | -118.67% | -13.94% |
Growth (annualized)
| Metric | ABOS | INGN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.02% |
| Total return CAGR (5Y) | -32.60% | -32.83% |
Frequently asked
- How have ABOS and INGN total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and INGN delivered -32.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.